Pneumococcal vaccination in autoimmune rheumatic diseases

É Rákóczi, Z Szekanecz - RMD open, 2017 - rmdopen.bmj.com
Streptococcus pneumoniae is the leading cause of the community-acquired pneumonia. The
mortality rate of invasive pneumococcal infections is high. Immunocompromised patients …

[HTML][HTML] Adaptive immunity to viruses: what did we learn from SARS-CoV-2 infection?

I Vályi-Nagy, F Uher, É Rákóczi… - International Journal of …, 2022 - mdpi.com
The SARS-CoV-2 virus causes various conditions, from asymptomatic infection to the fatal
coronavirus disease 2019 (COVID-19). An intact immune system can overcome SARS-CoV …

Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups

H Jiao, B Tóth, M Erdős, I Fransson, É Rákóczi… - Molecular …, 2008 - Elsevier
We performed clinical, immunological and genetic studies of 12 hyper-IgE syndrome (HIES)
patients from 4 Hungarian, 2 Lebanese, one Russian, one Polish, and one Swedish families …

COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients

Z Szekanecz, A Balog, T Constantin… - Expert Reviews in …, 2022 - cambridge.org
Coronavirus disease 2019 (COVID-19) is associated with autoimmunity and systemic
inflammation. Patients with autoimmune rheumatic and musculoskeletal disease (RMD) may …

Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept

É Rákóczi, B Perge, E Végh, P Csomor, A Pusztai… - Joint Bone Spine, 2016 - Elsevier
Objectives To prospectively evaluate the immunogenicity of a 13-valent conjugated
pneumococcal vaccine (PCV13) in rheumatoid arthritis (RA) patients undergoing etanercept …

[HTML][HTML] Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

Z Szekanecz, Z Vokó, O Surján, É Rákóczi… - Frontiers in …, 2023 - frontiersin.org
Introduction In Hungary, the HUN-VE 3 study determined the comparative effectiveness of
various primary and booster vaccination strategies during the Delta COVID-19 wave. That …

[HTML][HTML] Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine

É Rákóczi, G Magócs, S Kovács, B Nagy Jr, G Szűcs… - Diagnostics, 2023 - mdpi.com
Objectives: In this prospective study, SARS-CoV− 2 spike protein specific total
immunoglobulin (Ig) levels were analyzed before and after BNT162 b2 mRNA booster …

Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature

M Erdős, M Garami, É Rákóczi, A Zalatnai… - Clinical …, 2008 - Elsevier
X-linked hyper-immunoglobulin M syndrome (XHIGM) is a primary immunodeficiency
disorder characterized by severe defects of both cellular and humoral immunity due to …

[HTML][HTML] Severe Shwachman-Diamond syndrome phenotype caused by compound heterozygous missense mutations in the SBDS gene

M Erdős, K Alapi, I Balogh, G Oroszlán, É Rákóczi… - Experimental …, 2006 - Elsevier
OBJECTIVE: A 5-month-old male infant presenting with recurrent respiratory tract infections,
chronic diarrhea, and failure to thrive was found to be pancytopenic. Bone marrow and x-ray …

Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?

M Szilasi, J Mátyus, I File, G Szücs, É Rákóczi… - …, 2012 - Taylor & Francis
Objectives: There have been few reports on the association of rheumatoid arthritis (RA) with
anti-neutrophil cytoplasmic antigen (ANCA)-associated systemic vasculitides. Methods …